Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients

Silzle, T; Blum, S; Schuler, E; Kaivers, J; Rudelius, M; Hildebrande, B; Gattermann, N; Haas, R; Germing, U

Germing, U (reprint author), Heinrich Heine Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany.

BLOOD CANCER JOURNAL, 2019; 9 ():

Abstract

Lymphopenia is associated with an increased mortality in several medical conditions. Its prognostic impact in myelodysplastic syndromes (MDS) is less ......

Full Text Link